SurModics to Present at Oppenheimer Healthcare Conference
December 04 2013 - 8:00AM
Business Wire
Webcast is Live on Wednesday, December 11,
at 8:30 a.m. (CT)
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Andy LaFrence, vice president of
finance and chief financial officer, will make a presentation to
the investment community at the Oppenheimer Healthcare Conference
on Wednesday, December 11, 2013, at 8:30 a.m. CT
(9:30 a.m. ET) in New York City.
A live audio webcast of the presentation, with accompanying
slides, will be available by going to the investor relations
portion of the Company’s website at www.surmodics.com and clicking
on the webcast icon. The webcast will be archived on the Company’s
website beginning at 12:30 p.m. CT on Wednesday, December 11,
and will be available through Monday, March 10, 2014.
About SurModics, Inc.SurModics’ mission is to exceed our
customers’ expectations and enhance the well-being of patients by
providing the world’s foremost, innovative surface modification
technologies and in vitro diagnostic chemical components. The
Company partners with the world’s leading and emerging medical
device, diagnostic and life science companies to develop and
commercialize innovative products designed to improve patient
diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity,
prohealing, and biocompatibility capabilities; and components for
in vitro diagnostic test kits and microarrays. SurModics is
headquartered in Eden Prairie, Minnesota. For more information
about the Company, visit www.surmodics.com. The content of
SurModics’ website is not part of this press release or part of any
filings that the Company makes with the SEC.
SurModics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024